Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisis
Friday, 26 April 2024 ()
With revenues having more than doubled since 2019, to $10bn, US pharma group targets painkillers
With revenues having more than doubled since 2019, to $10bn, US pharma group targets painkillers
|
||||
You Might Like |